Latest Oncology Stories
BEIJING, May 29, 2015 /PRNewswire/ -- According to Dr.
ASCO Presentations Highlight Therapeutic Implications of PD-1/PD-L1 Expression and Interaction with Signaling Pathways in Patients with Colorectal and Pancreatic Cancers IRVING, Texas,
ASCO Presentations Showcase Utility of Caris Molecular Intelligence in Cataloging Disease Biomarkers in Gastrointestinal, Hepatic, Gynecologic and Renal Cancer Subtypes IRVING, Texas, May 29,
SAN DIEGO, May 29, 2015 /PRNewswire/ -- Epic Sciences announced today that the company will present single cell sequencing data, from metastatic castrate resistant prostate cancer patients,
VANCOUVER, British Columbia and MENLO PARK, Calif., May 29, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI)
DUBLIN, May 28, 2015 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/57tc8j/drug_delivery_in) has announced the addition of Jain PharmaBiotech's
INDIANAPOLIS, May 28, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced final results of the Phase III PROCLAIM trial that will also be discussed in an oral presentation at the American
ROCKLAND, Mass., May 28, 2015 /PRNewswire/ -- EMD Serono, the U.S.
Expanded physician access program, new awareness campaign, and clinical data presentations at ASCO highlight the Company's urine-based liquid biopsy service SAN DIEGO, May 28, 2015 /PRNewswire/
ASCO Presentations Shed Light on Biomarkers for Rare and Resistant GIST Subtypes and for Triple Wild-type Melanoma IRVING, Texas, May 28, 2015 /PRNewswire/ -- Caris Life Sciences,
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.